Serological Profile of Children and Young Adults with at Least One SARS-CoV-2 Positive Cohabitant: An Observational Study.
COVID-19
SARS-CoV-2
adolescents
children
family cluster
serological test
young adults
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
04 02 2021
04 02 2021
Historique:
received:
19
12
2020
revised:
20
01
2021
accepted:
31
01
2021
entrez:
9
2
2021
pubmed:
10
2
2021
medline:
12
2
2021
Statut:
epublish
Résumé
At the end of 2019, a new disease caused by the novel coronavirus SARS-CoV-2 appeared in Wuhan Province in China. Children seemed to be infected less frequently than adults, and family clusters seemed to play an important role in the spread of the pandemic. The aim of this study is to evaluate the serological profile of children and young adults between 4 and 16 years of age in order to assess the transmission patterns of COVID-19 between cohabitants. The subjects lived with at least one cohabitant who tested positive for the disease using a nasopharyngeal swab. To avoid contact with the disease, families were interviewed by telephone. Forty-nine children and adolescents with a mean age of 11 years were then subjected to a rapid lateral flow chromatographic test. Of them, seven (14.3%) were immunoglobulin G (IgG)-positive, and four (8.2%) were immunoglobulin M (IgM)-positive. In total, 16.3% of the tested sample had antibodies against SARS-CoV-2: this may confirm the lower vulnerability of children to COVID-19, despite the small sample size. The time from the negativization of the cohabitant until the test day may have influenced the results, especially when this timeframe is wide.
Identifiants
pubmed: 33557402
pii: ijerph18041488
doi: 10.3390/ijerph18041488
pmc: PMC7914765
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Acta Paediatr. 2020 Nov;109(11):2311-2312
pubmed: 32640088
J Med Virol. 2020 Sep;92(9):1518-1524
pubmed: 32104917
Cureus. 2020 Sep 12;12(9):e10413
pubmed: 33062530
Am J Otolaryngol. 2020 Sep - Oct;41(5):102573
pubmed: 32531620
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Cureus. 2020 May 20;12(5):e8207
pubmed: 32577325
World J Pediatr. 2020 Jun;16(3):267-270
pubmed: 32180140
PLoS One. 2020 Oct 22;15(10):e0240395
pubmed: 33091042
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Int J Environ Res Public Health. 2020 Sep 15;17(18):
pubmed: 32942560
Proc Biol Sci. 2015 Dec 22;282(1821):20143085
pubmed: 26702035
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Hosp Pediatr. 2021 Jan;11(1):71-78
pubmed: 33033078
Process Biochem. 2020 Nov;98:233-240
pubmed: 32843849
Pediatrics. 2021 Jan;147(1):
pubmed: 33033178
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Front Pediatr. 2020 Jun 23;8:386
pubmed: 32656172
JAMA. 2020 Apr 14;323(14):1335
pubmed: 32181795
BMC Pediatr. 2020 Sep 1;20(1):410
pubmed: 32873269
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
Pediatr Pulmonol. 2020 Aug;55(8):1892-1899
pubmed: 32492251
Indian Pediatr. 2020 Sep 15;57(9):820-826
pubmed: 32583808
JAMA. 2020 Apr 7;323(13):1313-1314
pubmed: 32058570
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
J Korean Med Sci. 2020 Mar 23;35(11):e124
pubmed: 32193905
J Infect. 2020 Jul;81(1):e28-e32
pubmed: 32283141
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004